Company Filing History:
Years Active: 2007
Title: Christopher G R Parsons: Innovator in Pharmaceutical Chemistry
Introduction
Christopher G R Parsons is a notable inventor based in Nidderau, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various neurological and immunological disorders. His work has implications for treating conditions that involve disturbances in neurotransmission.
Latest Patents
Christopher G R Parsons holds 1 patent related to azabicyclic, azatricyclic, and azaspirocyclic derivatives of aminocyclohexanes. This patent describes compounds that are systemically active as NMDA, 5HT, and nicotinic receptor antagonists. The pharmaceutical compositions derived from these compounds are designed to treat central nervous system disorders, immunomodulatory disorders, and exhibit activity against malaria, trypanosomiasis, Borne viruses, HSV, and Hepatitis C virus.
Career Highlights
Parsons is currently associated with Merz Pharma GmbH & Co. KGaA, where he continues to innovate in the pharmaceutical sector. His research focuses on developing new therapeutic agents that can effectively address complex health issues.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues such as Markus Henrich and Wojciech Danysz. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Christopher G R Parsons exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions are paving the way for new treatments that could significantly improve patient outcomes in various medical fields.